Large surface area microparticles cancer therapeutic platform designed for extended release at tumor site; direct tumor kill, immune response, and minimal side effects
Employees: 1-10
Founded date: 2015
Investors 1
| Date | Name | Website |
| - | Tenzing Ca... | tenzing.vc |
Mentions in press and media 4
| Date | Title | Description | Source |
| 07.03.2023 | NanOlogy Granted a US Patent for Its Investigational Drugs i... | NanOlogy LLC, a clinical-stage oncology company, announced issuance of a US patent titled: Local Del... | aithority.... |
| 03.05.2022 | Andera Partners supports Tubulis in a €60 million Series B f... | Andera Partners, a leading European private equity player, through its biotech and medtech practice ... | anderapart... |
| 25.07.2019 | Does the WRI’s new Sustainable Food Future report need an up... | In the southern Polish city of Katowice last December, news coverage of the UN’s COP 24 meeting on c... | agfunderne... |
| 31.05.2017 | Merck Ventures leads $11M round in solid tumor startup | Merck Ventures has led a $10.8 million (€9.6 million) investment in Inthera Bioscience. The series A... | fiercebiot... |